https://scholars.lib.ntu.edu.tw/handle/123456789/590537
標題: | Management of stroke in pregnancy and the puerperium | 作者: | SUNG-CHUN TANG JIANN-SHING JENG |
公開日期: | 2010 | 卷: | 10 | 期: | 2 | 起(迄)頁: | 205-215 | 來源出版物: | Expert Review of Neurotherapeutics | 摘要: | Pregnancy and the puerperium have been recognized to increase the risk of stroke, particularly from late pregnancy and through the puerperium. The reported incidences of stroke during pregnancy and the puerperium varied widely, ranging from 5 to 67 per 100,000 deliveries or pregnancies. Important causes of stroke during pregnancy and the puerperium include preeclampsia and eclampsia, cardioembolism, rupture of cerebral vascular anomaly, peripartum or postpartum cerebral angiopathy and cerebral venous thrombosis. Management of patients with pregnancy-related stroke is largely the same as that of nonpregnant patients, with more consideration on maternal and fetal risks. Low-dose aspirin reduces the occurrence of perinatal deaths and preeclampsia in women with historical risk factors for preeclampsia. Anticoagulation during pregnancy is indicated for current arterial or venous thromboembolism, prior venous thromboembolism on long-term anticoagulation, antiphospholipid syndrome with prior venous thromboembolism and patients with a mechanical heart valve. Data from thrombolytic therapy for pregnant women with acute ischemic stroke are limited. It is critical that the risks and benefits of thrombolytic therapy for pregnant women and fetuses are considered cautiously. ? 2010 Expert Reviews Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-76249112504&doi=10.1586%2fern.09.126&partnerID=40&md5=b1af960c7f0c65707fbbf2e032e7edb8 https://scholars.lib.ntu.edu.tw/handle/123456789/590537 |
ISSN: | 14737175 | DOI: | 10.1586/ern.09.126 | SDG/關鍵字: | acetylsalicylic acid; anticoagulant agent; heparin; low molecular weight heparin; African American; age distribution; anticoagulant therapy; antiphospholipid syndrome; artery thrombosis; blood clot lysis; blood vessel rupture; brain arteriovenous malformation; brain artery aneurysm; brain vein; cerebrovascular malformation; cesarean section; cleft palate; congenital malformation; drug safety; eclampsia; embolism; exophthalmos; fibrinolytic therapy; gastroschisis; heart disease; human; hypercoagulability; hypertension; incidence; insulin resistance; lipid metabolism; low drug dose; maternal mortality; neural tube defect; preeclampsia; pregnancy; pregnant woman; prosthetic valve thrombosis; puerperium; review; risk benefit analysis; risk factor; stroke; subarachnoid hemorrhage; thrombophilia; venous thromboembolism; Anticoagulants; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Complications; Puerperal Disorders; Risk Factors; Stroke |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。